Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver

Journal of Infectious Diseases

Volumn 197, Issue 3, 2008, Pages 355-360

  Ciesek, Sandra ^a   Helfritz, Fabian A ^a   Lehmann, Ulrich ^a   Becker, Thomas ^a   Strassburg, Christian P ^a   Neipp, Michael ^a   Ciner, Ayse ^a   Fytili, Paraskevi ^a   Tillmann, Hans L ^b   Manns, Michael Peter ^a   Wedemeyer, Heiner ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OCCULT HEPATITIS B; PRIORITY JOURNAL; RANDOMIZATION; VIRUS REACTIVATION;

DNA, VIRAL; FEMALE; HEPATECTOMY; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; VIRUS ACTIVATION;

EID: 39349095451     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/525286     Document Type: Article

References (15)

1. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007; 46:160-70.
2. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007; 136:699-712.
3. Cornberg M, Protzer U, Dollinger MM, et al. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: upgrade of the guideline, AWMF-register 021/011 [in German]. Z Gastroenterol 2007; 45:525-74.
4. Wiegand J, Jaeckel E, Cornberg M, et al. Long-term follow-up after successful interferon therapy of acute hepatitis C. Hepatology 2004; 40:98-107.
5. Wedemeyer H, Pethig K, Wagner D, et al. Long-term outcome of chronic hepatitis B in heart transplant recipients. Transplantation 1998; 66:1347-53.
6. Lehmann U, Wingen LU, Brakensiek K, et al. Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis. Hum Mol Genet 2007; 16:1335-42.
7. Kempinska A, Kwak EJ, Angel JB. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature. Clin Infect Dis 2005; 41:1277-82.
8. Madonia S, Orlando A, Scimeca D, Olivo M, Rossi F, Cottone M. Occult hepatitis B and infliximab-induced HBV reactivation. Inflamm Bowel Dis 2007; 13:508-9.
9. Raimondo G, Cacciamo G, Saitta C. Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? Ann Hepatol 2005; 4:100-6.
10. Fytili P, Ciesek S, Manns MP, et al. Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients. Transplantation 2006; 81:808-9.
11. Wagner D, Wagenbreth I, Stachan-Kunstyr R, Thoma HA, Hemmerling AE, Flik J. Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2, and S gene products. Clin Investig 1994; 72:350-2.
12. Kündig TM, Bachmann MF, Oehen S, et al. On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci U S A 1996; 93:9716-23.
13. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2:1104-8.
14. Weston SJ, Leistikow RL, Reddy KR, et al. Reconstitution of hepatitis C virus-specific T-cell mediated immunity after liver transplantation. Hepatology 2005; 41:72-81.
15. Marinos G, Rossol S, Carucci P, et al. Immunopathogenesis of hepatitis B virus recurrence after liver transplantation. Transplantation 2000; 69:559-68.